Status of Anti-Lung Cancer Drug Patents Applications in China from 2003 to 2012

E-ISSN： 2212-3970|9|2|221-240

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.9, Iss.2, 2014-05, pp. : 221-240

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stem Cell Patents: An Innovative Approach to Anti-Cancer Drug Discovery

Recent Patents on Anti-Cancer Drug Discovery, Vol. 5, Iss. 1, 2010-01 ,pp. : 14-21

Bentham Science Publishers

Access to resources Recommend Favorite

Lung Cancer Chemotherapy, New Treatment and Related Patents

Recent Patents on Anti-Cancer Drug Discovery, Vol. 9, Iss. 3, 2014-09 ,pp. : 372-381

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Status of Anti-Cancer Agents Derived from Marine Sources

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 6, 2008-08 ,pp. : 603-617

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Patents on Anti-Telomerase Cancer Therapy

Recent Patents on Anti-Cancer Drug Discovery, Vol. 7, Iss. 1, 2012-01 ,pp. : 102-117

Bentham Science Publishers

Access to resources Recommend Favorite

Epidermal growth factor receptor gene mutation status and its association with clinical characteristics and tumor markers in nonsmallcell lung cancer patients in Northwest China

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 847-850

Science Publishers

Access to resources Recommend Favorite